Detalles de la búsqueda
1.
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel.
Support Care Cancer
; 28(5): 2435-2442, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32048043
2.
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach.
Crit Rev Oncol Hematol
; 199: 104247, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38307393
3.
Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study.
Clin Lung Cancer
; 19(1): 93-104, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28645631
4.
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.
Lung Cancer
; 95: 73-81, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27040855
5.
Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the "tolerance" to targeted therapies already available for non-small cell lung cancer treatment in daily clinical practice.
Transl Lung Cancer Res
; 3(3): 173-80, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25806297
6.
Granulocyte colony-stimulating factors used in clinical practice: PoloNord Registry-Based Cohort Italian Study.
Tumori
; 100(5): 491-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25343541
Resultados
1 -
6
de 6
1
Próxima >
>>